Identification of the Epigenetic Response to Trauma (TrauMeth)

Rigshospitalet

Status: Completed

Conditions: Injuries; Trauma

Treatments: Diagnostic Test: Blood samples for DNA methylation analysis

Study type: Observational

Funder types: Other

Identifiers

NCT03974048

VD-2019-161

Details and patient eligibility

About

The objective of this study is to investigate potential early alterations in the DNA methylation profile after severe trauma and to investigate if the early marks persist.

Full description

Background: Severe trauma is an extreme physical exposure, which may have significant consequences for the patient. In addition to anatomical injury and hemodynamic compromise, severe trauma causes an immense and rapid systemic immune reaction. At the genomic level, trauma has been found to significantly increase gene expression in circulating leukocytes, and preliminary data is also emerging that trauma may even cause epigenetic (DNA methylation) alterations.

Epigenetics, including DNA methylation, have been suggested as a mediator of genetic risk and to play a significant role in subsequent non-traumatic disease. Within the field of trauma DNA methylation has only been sparsely studied, but a few studies of traumatized animals have suggested that DNA methylation alterations may occur in relation to trauma. Even though DNA methylation is highly dynamic, some marks have been found to be stable over time, and thus may have long-term consequences.

An increasing understanding of the role of epigenetics in disease development and response may pave the way for new treatment targets and modalities for multiple diseases including trauma.

Research question: Does trauma induce immediate (<4 hours) and persistent (30 days post-trauma) changes in the epigenome of peripheral blood cells, and do epigenetic changes correlate with patient recovery?

Objectives: To identify potential early alterations in the DNA methylation profile after severe trauma AND to investigate if the early marks persist.

Study design: A prospective, observational, cohort study of trauma patients admitted to RH's trauma center. The trauma cohort will be compared to a cohort of patients admitted for elective orthopedic surgery in terms of DNA methylation profile in blood cells pre-trauma/surgery, immediately post-trauma/surgery, and 30-45 days post-trauma/surgery.

DNA methylation profiles will be assessed by array technique using Illumina's MethylationEPIC Bead-Chip.

Primary outcome: Immediate (<4 hours) post-trauma DNA methylation profile in blood cells.

Secondary outcomes: Pre-trauma/surgery DNA methylation profile, change in DNA methylation from pre-trauma/surgery to immediately and 30 days post-trauma/surgery, occurrence of organ dysfunction, sepsis, septic shock, 30-day mortality, ICU admission > 24 hours, ICU length of stay (LOS), hospital LOS.

Enrollment: 365 patients

Sex: All

Ages: 18 to 65 years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• Age 18-65 years.

• Trauma patients: Admitted to Rigshospitalet's trauma center generating a trauma team activation.

• Surgical controls: Admitted for elective surgery (non-traumatic cause) at the orthopedics department AND

  • Only one surgical procedure planned from study day 0 to study day 45.
  • Expected procedure length of at least 60 minutes.

Exclusion criteria

• Not able to obtain informed consent and not possible to obtain consent from a next-of-kin.

• Trauma patients:

  • Secondary transfers.
  • Pre-hospital blood transfusion OR blood transfusion in the trauma center before the first blood sample is obtained.
  • First blood sample taken later than 4 hours after the trauma.
  • Patients in cardiac arrest before/after hospital admission.
  • Additional traumatic exposure requiring hospital admission between the collection of the primary blood sample and the follow-up blood sample (will cause exclusion from follow-up blood sample).
  • Surgery not related to the trauma between the collection of the primary blood sample and the follow-up blood sample (will cause exclusion from follow-up blood sample).

• Surgical controls:

  • Surgical procedures due to cancer or fractures.
  • Traumatic exposure requiring hospital admission between the collection of the primary blood sample and the follow-up blood sample (will cause exclusion from follow-up blood sample).
  • Additional, unplanned surgery between the collection of the primary blood sample and the follow-up blood sample (will cause exclusion from follow-up blood sample).
  • First post-operative blood sample taken later than 4 hours after surgical end time.

Trial design

365 participants in 2 patient groups

Trauma patients

Description:

All trauma patients admitted to Rigshospitalet's trauma center will have a blood sample taken during the initial treatment and 30 days after the trauma.

Treatment:

Diagnostic Test: Blood samples for DNA methylation analysis

Patients admitted for elective orthopedic surgery

Description:

The patients will have a blood sample taken before and after surgery and again 30 days after the surgery.

Treatment:

Diagnostic Test: Blood samples for DNA methylation analysis